We are live on
!
Find out more
AF
Atlas FRM Portfolio holdings
AUM
$1.53B
1-Year Est. Return
14.94%
This Fund
S&P 500
This Quarter
Est. Return
+10.99%
1 Year Est. Return
-14.94%
3 Year Est. Return
+17.86%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$605M
AUM Growth
+$82.5M
(+16%)
Cap. Flow
+$24.8M
Cap. Flow
% of AUM
4.09%
Top 10 Holdings %
Top 10 Hldgs %
99.8%
Holding
11
New
2
Increased
2
Reduced
3
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
International Paper
IP
|
+$20.4M |
| 2 |
Tyson Foods
TSN
|
+$13.3M |
| 3 |
Packaging Corp of America
PKG
|
+$10.2M |
| 4 |
Cal-Maine
CALM
|
+$9.29M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WRK
WestRock Company
WRK
|
+$19.7M |
| 2 |
Suzano
SUZ
|
+$4.51M |
| 3 |
Pilgrim's Pride
PPC
|
+$4.26M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Materials | 52.14% |
| 2 | Consumer Discretionary | 39.51% |
| 3 | Consumer Staples | 8.35% |
Similar funds
PAG
HR
SG
FI
ACL
MCP
CCM
KCM
Atlas FRM's Q3 2023 Portfolio in Review
As of Q3 2023, Atlas FRM held 11 positions worth $605M, up 16% from $523M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Atlas FRM deployed $24.8M of net new capital in Q3 2023, opening 2 new positions and adding to 2 existing holdings. Its largest new stake was Tyson Foods: 250,000 shares worth $12.6M.
By sector, the portfolio is most concentrated in Materials at 52% of assets, down from 56% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.
On the sell side, the largest reduction was WestRock Company, an estimated $19.7M trimmed.
- Atlas FRM's largest Q3 2023 buy was Tyson Foods: 250,000 shares worth $12.6M.
- Atlas FRM added most to International Paper in Q3 2023, an estimated $20.4M increase.
- Atlas FRM's biggest Q3 2023 reduction was WestRock Company, cutting an estimated $19.7M.
- Atlas FRM's ten largest holdings make up 100% of its $605M portfolio in Q3 2023.
- Atlas FRM opened 2 new positions and closed 0 in Q3 2023.
- Atlas FRM's portfolio value rose 16% quarter-over-quarter to $605M.
Based on Atlas FRM's 13F filing for Q3 2023, filed 13 Nov 2023.